Private Equity

  • September 24, 2026

    PE And Activist-Driven Moves Lead The Week's Deal Rumors

    Activist investors are turning up the pressure on companies including Six Flags Entertainment and Knife River, while private equity firms GTCR and Reverence Capital are weighing a sale of asset manager Allspring Global Investments, and Clayton Dubilier & Rice and Warburg Pincus are in talks to jointly acquire Canaccord Wealth.

  • September 24, 2026

    SPAC Settlements Drove Down Chancery Deal Values In 2025

    A surge in the number of settlements in the Delaware Chancery Court last year was driven by the end of litigation against special purpose acquisition vehicles, but settling investors received less money than at any point in the past five years, Cornerstone Research has said in a new report.

  • September 24, 2026

    Enterprise AI Biz Valued At $6.4B After Latest Funding

    Enterprise-focused artificial intelligence company Island on Thursday revealed that its valuation soared to $6.4 billion after it closed its latest funding round with $400 million in tow.

  • September 24, 2026

    Troutman Adds Finn Dixon Investment Management Leader

    Troutman Pepper Locke LLP has grown its Connecticut outpost with the addition of Finn Dixon & Herling LLP's former investment management practice leader.

  • September 24, 2026

    Fried Frank Adds DLA Piper Asset Management Partner In DC

    Fried Frank Harris Shriver & Jacobson LLP has hired a partner from DLA Piper who focuses his practice on counseling sponsors and managers of private funds through regulatory matters, the firm recently announced.

  • September 23, 2026

    Conn. Panel Seeks Info On Intervenor Standing In Setoff Case

    A Connecticut appellate court has asked for more information about whether intervenors challenging caps that could cut millions of dollars of benefits in a state-managed rehabilitation of PHL Variable Insurance Co. are actual policyholders who have standing to be involved in an appeal.

  • September 23, 2026

    Curium Resets FTC Clock On $8B Lantheus Take-Private Deal

    Private equity-backed radiopharmaceutical company Curium reset the clock for the Federal Trade Commission's 30-day review of its plan to acquire fellow radiopharmaceutical company Lantheus Holdings Inc. in an $8 billion take-private deal.

  • September 23, 2026

    Vividion Investor Wants IP Suit Over $2B Bayer Deal Revived

    CHP III LP urged the Delaware Supreme Court on Wednesday to revive its suit over allegedly diverted intellectual property in Vividion Therapeutics Inc.'s $2 billion sale to Bayer Corp., while the defendants argued the investor is trying to turn a corporate injury into a direct stockholder claim that did not survive the merger.

  • September 23, 2026

    GoldenTree Plugs $482.5M Into Colorado Ski Resort Project

    Stockman Development LLC on Wednesday revealed that it secured $482.5 million in new funding from GoldenTree Asset Management to advance its residential and resort The Stockman, Auberge Collection project in Colorado.

  • September 23, 2026

    Bessemer Secures $5.75B In New Capital To Back Founders

    Venture capital firm Bessemer Venture Partners, advised by Kirkland & Ellis LLP, on Wednesday revealed that it has raised $5.75 billion in new funding, which will be used to back companies "shaping" the artificial intelligence space.

  • September 23, 2026

    FedEx-Led €7.8B Acquisition Of InPost Wins Approvals

    FedEx and U.S. private equity firm Advent International said Wednesday that their approximately €7.8 billion ($8.9 billion) offer to acquire parcel locker business InPost has cleared all the necessary conditions required for the transaction.

  • September 22, 2026

    Healthcare PE Firm Sues Real Estate PE Firm Over 'Ironleaf' TM

    Healthcare technology-focused private equity firm Ironleaf Capital LP is accusing real estate private equity firm Ironleaf Equity Partners LLC in Washington federal court of infringing its "Ironleaf" and "Ironleaf Capital" trademarks by being a similarly named private equity firm.

  • September 22, 2026

    Healthcare AI Biz Valued At $900M After $100M Series C Round

    Healthcare-focused artificial intelligence company Heidi on Tuesday revealed that it has reached a $900 million valuation after raising $100 million in its latest funding round.

  • September 22, 2026

    Yale, Biohaven Seek $23M Atty Fee After Trade Secrets Win

    Yale University and Biohaven Therapeutics Ltd. have requested attorney fees topping $23.1 million, plus $2 million each in exemplary damages, after winning a $4 million trial verdict, though both entities are also seeking a new trial to readdress damages on trade secrets and contract breach claims.

  • September 22, 2026

    Data Center Power Provider Accelevation Eyes $660M IPO

    Data center power provider Accelevation Holdings on Tuesday outlined a price range for an estimated $660 million initial public offering steered by Kirkland & Ellis LLP and Simpson Thacher & Bartlett LLP.

  • September 22, 2026

    Juul Buyers Defend Antitrust Classes At 9th Circ.

    Juul buyers are defending the certification of several classes in a case over tobacco giant Altria's past investment in the e-cigarette company, telling the Ninth Circuit it does not matter if they purchased different quantities on different terms or live in different states.

  • September 22, 2026

    Paul Weiss Lands Weil Private Equity Co-Head In NY

    Paul Weiss Rifkind Wharton & Garrison LLP has hired a team of transactional lawyers, including the co-head of Weil Gotshal & Manges LLP's private equity practice, the firm announced on Tuesday.

  • September 22, 2026

    Rentokil To Sell Lake Management Arm To Bain For $230M

    Global pest control company Rentokil said Tuesday it has agreed to sell its lake and pond management division to U.S. asset manager Bain Capital for $230 million.

  • September 22, 2026

    CMA Seeks Views On Kone's €29.4B Deal For German Rival

    The antitrust authority said Tuesday it is seeking initial views on whether Finnish lift engineering giant Kone's planned €29.4 billion ($33.7 billion) acquisition of TK Elevator GmbH could harm competition in the U.K.

  • September 21, 2026

    Ex-PetIQ CEO's Brother Admits To Illicit Trades Over Deal Info

    An Idaho man pled guilty Monday in federal court to trading on confidential information he received from his brother, the former CEO of PetIQ, about the company's acquisition by Bansk Group in August 2024.

  • September 21, 2026

    Endeavor, Silver Lake Sue To Block Appraisal Claims

    Endeavor Group Holdings Inc. and Silver Lake Technology Management LLC on Monday sued dozens of hedge funds and other investors in Delaware Chancery Court, seeking to block them from pursuing appraisal claims over Silver Lake's $27.50 per-share buyout of Endeavor and alleging that many bought shares only after the deal was announced to profit from litigation.

  • September 21, 2026

    FTX Trust Says SkyBridge Can't Collect $53M In Ch. 11 Claims

    FTX's liquidating trust is asking a Delaware bankruptcy judge to reject $53 million in claims from firms affiliated with a former Trump administration official, saying the companies came out ahead of deals at issue in the case.

  • September 21, 2026

    Latham, Milbank Guide AI Hyperscaler Nscale's IPO Plans

    United Kingdom-based Nscale, a Latham & Watkins LLP-advised data center developer, filed for an initial public offering, reporting that $88.4 billion in contracted work for its two largest customers, Microsoft and Anthropic, made up 83% of the company's backlog.

  • September 21, 2026

    Catching Up With Delaware's Chancery Court

    The Delaware Chancery Court this past week dismissed a challenge to Alteryx Inc.'s $4.4 billion take-private sale, resolved a fight over the removal of a security technology company's director and declined to let Empery Digital Inc. immediately appeal a proxy contest ruling.

  • September 21, 2026

    Smart-Ring Maker Oura Launches $2.1B IPO Plan

    Fitness-tracking ring maker Oura on Monday unveiled a target price range for its public debut, telling the U.S. Securities and Exchange Commission that it plans to raise roughly $2.1 billion.

Expert Analysis

  • NJ Supreme Court Ruling Exposes D&O Gaps For PE Boards

    Author Photo

    The New Jersey Supreme Court's recent decision in Mist Pharmaceuticals v. Berkley Insurance, barring directors and officers coverage, serves as a cautionary tale for private equity executives serving in overlapping roles at sponsor and portfolio companies, say attorneys at Reed Smith.

  • Series

    Teaching SEC Investigations Makes Me A Better Lawyer

    Author Photo

    Instructing a law school course on U.S. Securities and Exchange Commission investigations has made me a more thoughtful, deliberate practitioner because it requires me to continually reassess and challenge what I know about securities law enforcement, how I know it and how best to explain it, says David Chase at Miami Law.

  • What New USDA 'Beneficial Owner' Definition Means For Cos.

    Author Photo

    The U.S. Department of Agriculture's recent pitch to add a new "beneficial owner" definition to its foreign-owned land reporting framework would overhaul how fund managers and joint venture participants report U.S. agricultural land interests, creating diligence risks as companies reassess governance rights and management structure, say attorneys at Arnold & Porter.

  • Series

    Judges On AI: Examining Administrative, Organizational Uses

    Author Photo

    U.S. District Judge Alan Albright of the Western District of Texas examines how artificial intelligence could transform a court's ability to deal with administrative work and organize materials when preparing for hearings or drafting opinions, thereby affording judges more time to resolve contested issues.

  • Series

    Being A Singer Makes Me A Better Lawyer

    Author Photo

    Before law school, I spent seven years trying to make it as a professional singer in Los Angeles, and nearly everything I learned about preparation, humility, confidence and more has followed me into my legal practice, says Jessica Caterina at Moses & Singer.

  • Parsing Who Gets The Track Record In A Venture Partner Split

    Author Photo

    A recent California federal court order in TEEC Angel Management v. Tsingyuan Ventures allowing Lanham Act claims to proceed confirms that the question of who gets to tell the story of a shared win is now being litigated as false advertising instead of industry professional etiquette, says Ben Dubin at VC Expert Services.

  • $400M Serta Ruling Offers Warning On Uptier Deal Risks

    Author Photo

    A Texas bankruptcy court's recent remand ruling, which disallowed Serta Simmons Bedding’s uptier debt exchange and awarded $400 million to the minority lenders, demonstrates why deal counsel negotiating similar agreements should clearly define exceptions and lien subordination, while litigators should lean on express terms, says Jamie Aycock at Yetter Coleman.

  • Navigating OFAC's 50% Rule For Cross-Border Exec Mobility

    Author Photo

    A recent Office of Foreign Assets Control guide signals that its 50% ownership rule can determine not only sanctions compliance but also whether a company can sponsor multinational executives for immigration, highlighting an often overlooked interaction between sanctions and immigration law, says Xuan Zhang at Reid & Wise.

  • Carbon Health Settlement Highlights Why Evidence Is Key

    Author Photo

    The California Attorney General's Office's first-of-its-kind settlement with Carbon Health, imposing penalties for alleged corporate practice of medicine violations, shows that friendly professional corporation challenges usually hinge not on the parties' management services agreement, but on whether the operational record matches it, says Ben Dubin at VC Expert Services.

  • What PE Practitioners Need To Know About New Del. ABC Act

    Author Photo

    Delaware's new Assignment for the Benefit of Creditors statute represents a structural shift in how companies backed by private equity can be wound down and provides a more streamlined tool for managing sponsor liability without the public visibility of a bankruptcy proceeding, says Evelyn Meltzer at Troutman Pepper.

  • Assessing New Risks After The End Of The SEC's Gag Rule

    Author Photo

    The U.S. Securities and Exchange Commission's recent rescission of its long-standing no‑deny gag rule marks a transition from a regime of enforced silence to one of strategic communication, meaning the question is no longer simply whether to settle, but how to manage the narrative that follows, say attorneys at Nelson Mullins.

  • Series

    Being A Magician Makes Me A Better Lawyer

    Author Photo

    The skills I've developed as a lifelong magician have translated directly into tangible benefits in the courtroom because performing magic and trying cases both live at the intersection of psychology, storytelling, timing and disciplined rehearsal, says Mark Dombroff at Fox Rothschild.

  • Future Of Fed Independence Shaky After Justices' Ruling

    Author Photo

    The U.S. Supreme Court's recent ruling in Trump v. Cook preserved the Federal Reserve's formal independence but could invite the president to remove board members with just modest protections, leaving the central bank's autonomy uncertain and potentially setting up fresh clashes over other agencies, says Steven Schwinn at the University of Chicago.

  • Fiduciary Duty Risks In Continuation Vehicle Transactions

    Author Photo

    Continuation vehicle transactions have become prominent in private equity, but conflicts may arise due to transaction structures and implicate fiduciary duties, with a recent Delaware case highlighting several procedural considerations for sponsors, say attorneys at Debevoise.

  • A New Regulatory Environment For PE In Calif. Healthcare

    Author Photo

    The California Office of Health Care Affordability's proposed revisions to its cost and market impact review regulations, amid broader state scrutiny of private equity-backed healthcare arrangements, represent a qualitative shift in California's regulatory posture toward institutional healthcare investment, say attorneys at Ropes & Gray.

Want to publish in Law360?


Submit an idea

Have a news tip?


Contact us here
Can't find the article you're looking for? Click here to search the Private Equity archive.